Loss of Taste and Smell are Common Clinical Characteristics of Patients with COVID-19 in Somalia: A Retrospective Double Centre Study.

Autor:	Farah Yusuf Mohamud M; Mogadishu Somali-Turkish Training and Research Hospital, Mogadishu, Somalia., Garad Mohamed Y; Mogadishu Somali-Turkish Training and Research Hospital, Mogadishu, Somalia., Mohamed Ali A; Mogadishu Somali-Turkish Training and Research Hospital, Mogadishu, Somalia., Ali Adam B; Mogadishu Somali-Turkish Training and Research Hospital, Mogadishu, Somalia.
Jazyk:	angličtina
Zdroj:	Infection and drug resistance [Infect Drug Resist] 2020 Jul 29; Vol. 13, pp. 2631-2635. Date of Electronic Publication: 2020 Jul 29 (Print Publication: 2020).
DOI:	10.2147/IDR.S263632
Abstrakt:	Purpose: The purpose of this study was to identify the common clinical presentations and the evidence on the presence of ageusia and anosmia as an emerging coronavirus disease 2019 (COVID-19) symptom to better inform in both COVID-19 patients and clinicians. Patients and Methods: As part of a double-institutional collaboration coordinated by doctors, this study retrospectively collected and analyzed the clinical characteristics of 60 patients with COVID-19 pneumonia between April 1 and April 20, 2020. Pregnant women and patients taking anti-cancer drugs had been excluded from the study. Data from each institution's electronic medical record had been obtained. Results: Sixty patients who had RT-PCR positive for COVID-19 were included in this study; of these patients, all of them had unknown exposure to COVID-19. The mean (SD) age was 45.7 (13.5) years, and 42 were men (70%). Of these patients, 80% had at least ageusia or anosmia. The most common symptoms at the onset of illness were cough (75%), fever (71.3%), myalgia or fatigue (53.3%), anosmia (loss of smell) (40%), ageusia (loss of taste) (28.3%), sore throat (25%), shortness of breath (16.7%), headache (16.7%), and GI symptoms (diarrhea, nausea, vomiting and loss appetite) (16.7%). A total of 68.3% of COVID-19 infected patients had reported either loss of taste or smell, and about 33.3% of them had only loss of smell, while 23.3% of them had impaired taste, and 11.7% of COVID-19 infected patients had both taste and smell loss. Conclusion: During the epidemic period of SARS-CoV-2 infection, when presenting patients with ageusia and anosmia, physicians should consider COVID-19 pneumonia as a differential diagnosis to achieve early identification, avoid the delayed diagnosis, and prevention of transmission. Competing Interests: The authors report no conflicts of interest in this work. (© 2020 Farah Yusuf Mohamud et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu